Australia markets closed

HCA Healthcare, Inc. (HCA)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
215.55+3.76 (+1.78%)
At close: 04:00PM EDT
215.45 -0.10 (-0.05%)
After hours: 06:29PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 60.02B
Enterprise value 97.14B
Trailing P/E 9.60
Forward P/E 11.72
PEG ratio (5-yr expected) 1.13
Price/sales (ttm)1.09
Price/book (mrq)N/A
Enterprise value/revenue 1.63
Enterprise value/EBITDA 6.86

Trading information

Stock price history

Beta (5Y monthly) 1.61
52-week change 3-0.15%
S&P500 52-week change 3-1.04%
52-week high 3279.02
52-week low 3198.69
50-day moving average 3235.28
200-day moving average 3244.91

Share statistics

Avg vol (3-month) 31.91M
Avg vol (10-day) 31.68M
Shares outstanding 5295.48M
Implied shares outstanding 6N/A
Float 8222.76M
% held by insiders 124.35%
% held by institutions 168.63%
Shares short (12 May 2022) 45M
Short ratio (12 May 2022) 41.99
Short % of float (12 May 2022) 42.23%
Short % of shares outstanding (12 May 2022) 41.69%
Shares short (prior month 13 Apr 2022) 43.95M

Dividends & splits

Forward annual dividend rate 42.24
Forward annual dividend yield 41.09%
Trailing annual dividend rate 32.00
Trailing annual dividend yield 30.94%
5-year average dividend yield 4N/A
Payout ratio 49.45%
Dividend date 329 June 2022
Ex-dividend date 414 June 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 11.40%
Operating margin (ttm)15.98%

Management effectiveness

Return on assets (ttm)11.99%
Return on equity (ttm)525.28%

Income statement

Revenue (ttm)59.72B
Revenue per share (ttm)189.95
Quarterly revenue growth (yoy)6.90%
Gross profit (ttm)22.49B
EBITDA 12.43B
Net income avi to common (ttm)6.81B
Diluted EPS (ttm)21.29
Quarterly earnings growth (yoy)-10.50%

Balance sheet

Total cash (mrq)2.48B
Total cash per share (mrq)8.38
Total debt (mrq)39.49B
Total debt/equity (mrq)9,538.16
Current ratio (mrq)1.43
Book value per share (mrq)-6.80

Cash flow statement

Operating cash flow (ttm)8.32B
Levered free cash flow (ttm)3.52B